Thermo Fisher Scientific Inc (TMO-RM)

35,433.00
+6.00(+0.02%)
  • Volume:
    45
  • Bid/Ask:
    35,433.00/35,433.00
  • Day's Range:
    35,234.00 - 35,560.00

TMO-RM Overview

Prev. Close
35,429
Day's Range
35,234-35,560
Revenue
-
Open
35,407
52 wk Range
31,800-38,303
EPS
-
Volume
45
Market Cap
14.1T
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
77
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
-
Next Earnings Date
-
What is your sentiment on Thermo Fisher Scientific Inc?
or
Market is currently closed. Voting is open during market hours.

Thermo Fisher Scientific Inc News

Thermo Fisher Scientific Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Thermo Fisher Scientific Inc Company Profile

Thermo Fisher Scientific Inc Company Profile

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.

Read More
  • good news for TMO,, moderna :announces agreement with TMO for finish manufacturing of moderna covid 19 vaccine 😁
    0
    • A Valid reason for going down
      0
  • What happened??
    0
    • Musn here we go?129?
      0
  • You North Americans do not use this web/app for forums communications... where is people? Where takes place the stock market discussion?
    0
    • Twitter etc
      0
    • Let's discuss bro
      0
  • RDGL approval or denial by Jan 16 by the FDA for breakthrough designation for their tumor fighting drug
    0
    • Needham analyst Stephen Unger reiterated a Buy rating on Thermo Fisher on Wednesday, setting a price target of $539
      0
      • "The first days of Pfizer Inc (NYSE:PFE)'s COVID-19 vaccine rollout have seen unexpected hitches including some vaccines being stored at excessively cold temperatures"  >>  with a TMO refrigerator this would not have happened!!  ;)
        0
        • The demand for freezers is not surprising
          0
          • This update will include expected fourth quarter organic revenue growth of 40%, compared to the original expected fourth quarter organic revenue growth of 29% that the Company provided on October 21
            0
            • http://d18rn0p25nwr6d.cloudfront.net/CIK-0000097745/068289de-d80f-4b52-8cd4-d54363903868.pdf
              0
          • smells like bullcrap
            1
            • Ultra cold vaccine freezer avg. cost is $10,000 x (1,200 + 6,210) [the number of clinics + hospitals in the US] = $74,1M  is it ok?  Not bad for TMO
              0
              • Now imagine that instead of having 1 per hospital they want to have 7 freezers to go faster vaccinating
                0
              • Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
                0
            • There plenty room to 🏃‍♂️ 🏃‍♀️ 🏃‍♂️ 🏃‍♀️
              0
              • if you think this company is overvalued please dislike and if you think that there is more than 10 % upside potential please give a like
                5
                • plunged to 289 then 407, weird...
                  2
                  • 339,76 after market???
                    0
                    • 400+
                      0
                      • What’s the deal with TMO? Looks poised to pop.
                        0
                        • sip sip lets go TMO
                          0
                          • meh this market is horrible even when your trying to help it
                            0
                          • Hyborian War I am amazed as to how you could reply the day before you made the comment!
                            0
                          • Coffee Man  the investing gods got nothing on me now lets go TMO
                            0
                        • A lot of upside potential in this stock, solid outlook and good fundementals.
                          0
                          • I love these “Under the radar” kind of stocks.. a great performer with super string product demand tgat will last 20 years at least!
                            0
                            • Fantastic company
                              0
                              • +1
                                0
                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.